RESEARCH AND TECHNOLOGY AGREEMENTResearch and Technology Agreement • May 11th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware
This Research and Technology Agreement (the “Agreement”) is made effective as of January 24, 2001 (the “Effective Date”) between INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation, having its principal place of business in Mountain View, California (hereinafter referred to as “INTRABIOTICS”), and NEW CHEMICAL ENTITIES, INC., a Delaware corporation having a principal place of business in Bothell, Washington (hereinafter referred to as “NCE”).
DRUG DISCOVERY, DEVELOPMENT, AND LICENSE AGREEMENT by and between DIVERSA CORPORATION and INTRABIOTICS PHARMACEUTICALS, INC.Drug Discovery, Development, and License Agreement • May 11th, 2001 • Intrabiotics Pharmaceuticals Inc /De • Pharmaceutical preparations • California
THIS DRUG DISCOVERY, DEVELOPMENT, AND LICENSE AGREEMENT, dated and effective as of January 6, 2001 (the “Effective Date”), is by and between DIVERSA CORPORATION, a Delaware corporation (“Diversa”), having its principal place of business at 4955 Directors Place, San Diego, California 92121, and INTRABIOTICS PHARMACEUTICALS, INC., a Delaware corporation (“IBP”), having its principal place of business at 2021 Stierlin Court, Mountain View, California 94043 (collectively, the “Parties”).
